RM

Rahman Momina

Active Director Director DIN 08613492
DIN 08613492 First appointment Nov 2019 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2019
Shareholding value •••• Premium profile

About Rahman Momina

Data last updated:

Rahman Momina is a Director at Hilfen Pharmaceuticals Private Limited (since 2019). The company operates in Business Services. Hilfen Pharmaceuticals Private Limited reported revenue of ₹2.16 Cr (FY 2024).

DIN 08613492
Primary Designation Director
Industry Business Services
First Appointment 21 Nov 2019
Oldest Company Age 6 yrs
Largest company Hilfen Pharmaceuticals Private Limited · ₹2.16 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Nov 20192019₹2.16 Cr (FY 2024)Active

Board colleagues of Rahman Momina

Directorship timeline

Open interactive timeline →
Hilfen Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rahman Momina

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahman Momina

Rahman Momina currently holds 1 directorship: Hilfen Pharmaceuticals Private Limited (Director, since 21 Nov 2019, revenue ₹2.16 Cr (FY 2024)).

Rahman Momina was first appointed on 21 Nov 2019 as Director at Hilfen Pharmaceuticals Private Limited.

The current boards of Rahman Momina's companies include Naser Ahmed (Hilfen Pharmaceuticals Private Limited), Parvin Afroza (Hilfen Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available